Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Depression, anxiety, cognitive impairment and their association with clinical and demographic variables in people with type 2 diabetes: a 4-year prospective study.

Trento M, Trevisan M, Raballo M, Passera P, Charrier L, Cavallo F, Porta M.

J Endocrinol Invest. 2014 Jan;37(1):79-85. doi: 10.1007/s40618-013-0028-7. Epub 2014 Jan 8.

PMID:
24464454
2.

Depression, anxiety and cognitive function in patients with type 2 diabetes: an 8-year prospective observational study.

Trento M, Charrier L, Salassa M, Merlo S, Passera P, Cavallo F, Porta M.

Acta Diabetol. 2015 Dec;52(6):1157-66. doi: 10.1007/s00592-015-0806-0. Epub 2015 Sep 16.

3.

A cross-sectional survey of depression, anxiety, and cognitive function in patients with type 2 diabetes.

Trento M, Raballo M, Trevisan M, Sicuro J, Passera P, Cirio L, Charrier L, Cavallo F, Porta M.

Acta Diabetol. 2012 Jun;49(3):199-203. doi: 10.1007/s00592-011-0275-z. Epub 2011 Mar 27.

4.

[Diabetes self-management and its association with diabetic retinopathy in patients with type 2 diabetes].

Li N, Yang XF, Deng Y, Gu H, Ren XT, Xu J, Ma K, Liu NP.

Zhonghua Yan Ke Za Zhi. 2013 Jun;49(6):500-6. Chinese.

PMID:
24119962
5.

Cognitive function may be a predictor of retinopathy progression in patients with type 2 diabetes.

Trento M, Charrier L, Salassa M, Merlo S, Passera P, Baltatescu A, Cavallo F, Porta M.

Eur J Ophthalmol. 2017 May 11;27(3):278-280. doi: 10.5301/ejo.5000885. Epub 2016 Oct 3.

PMID:
27716894
6.

Association Between Diabetes-Related Eye Complications and Symptoms of Anxiety and Depression.

Rees G, Xie J, Fenwick EK, Sturrock BA, Finger R, Rogers SL, Lim L, Lamoureux EL.

JAMA Ophthalmol. 2016 Sep 1;134(9):1007-14. doi: 10.1001/jamaophthalmol.2016.2213.

PMID:
27387297
7.

Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2.

Plastino M, Fava A, Pirritano D, Cotronei P, Sacco N, Sperlì T, Spanò A, Gallo D, Mungari P, Consoli D, Bosco D.

J Neurol Sci. 2010 Jan 15;288(1-2):112-6. doi: 10.1016/j.jns.2009.09.022.

PMID:
19836029
8.

Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.

Ding J, Strachan MW, Reynolds RM, Frier BM, Deary IJ, Fowkes FG, Lee AJ, McKnight J, Halpin P, Swa K, Price JF; Edinburgh Type 2 Diabetes Study Investigators.

Diabetes. 2010 Nov;59(11):2883-9. doi: 10.2337/db10-0752. Epub 2010 Aug 26.

9.

Total homocysteine and cognitive deterioration in people with type 2 diabetes.

de Luis DA, Fernandez N, Arranz M, Aller R, Izaola O.

Diabetes Res Clin Pract. 2002 Mar;55(3):185-90.

PMID:
11850094
10.

Retinopathy, nephropathy, peripheral neuropathy and geriatric scale scores in elderly people with Type 2 diabetes.

Le Floch JP, Doucet J, Bauduceau B, Verny C; SFD/SFGG Intergroup.

Diabet Med. 2014 Jan;31(1):107-11. doi: 10.1111/dme.12327. Epub 2013 Oct 21.

PMID:
24111927
11.

Symptoms and complications of adult diabetic patients in a family practice.

Konen JC, Curtis LG, Summerson JH.

Arch Fam Med. 1996 Mar;5(3):135-45.

PMID:
8620254
12.

The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Hugenschmidt CE, Lovato JF, Ambrosius WT, Bryan RN, Gerstein HC, Horowitz KR, Launer LJ, Lazar RM, Murray AM, Chew EY, Danis RP, Williamson JD, Miller ME, Ding J.

Diabetes Care. 2014 Dec;37(12):3244-52. doi: 10.2337/dc14-0502. Epub 2014 Sep 5.

13.

Anxiety, depression and timing of insulin treatment among people with type 2 diabetes: Nine-year follow-up of the Nord-Trøndelag Health Study, Norway.

Iversen MM, Nefs G, Tell GS, Espehaug B, Midthjell K, Graue M, Pouwer F.

J Psychosom Res. 2015 Oct;79(4):309-15. doi: 10.1016/j.jpsychores.2015.07.004. Epub 2015 Jul 16.

PMID:
26208403
14.

Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.

Savage S, Estacio RO, Jeffers B, Schrier RW.

Proc Assoc Am Physicians. 1997 Mar;109(2):181-9.

PMID:
9069587
15.

Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial.

Cukierman-Yaffe T, Bosch J, Diaz R, Dyal L, Hancu N, Hildebrandt P, Lanas F, Lewis BS, Marre M, Yale JF, Yusuf S, Gerstein HC; ORIGIN Investigators.

Lancet Diabetes Endocrinol. 2014 Jul;2(7):562-72. doi: 10.1016/S2213-8587(14)70062-2. Epub 2014 Jun 2.

PMID:
24898834
16.

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M.

Diabetes Res Clin Pract. 1995 May;28(2):103-17.

PMID:
7587918
17.

Systolic hypertension and duration of diabetes mellitus are important determinants of retinopathy and microalbuminuria in young diabetics.

Wan Nazaimoon WM, Letchuman R, Noraini N, Ropilah AR, Zainal M, Ismail IS, Wan Mohamad WB, Faridah I, Singaraveloo M, Sheriff IH, Khalid BA.

Diabetes Res Clin Pract. 1999 Dec;46(3):213-21.

PMID:
10624787
18.

Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.

Emanuele N, Klein R, Abraira C, Colwell J, Comstock J, Henderson WG, Levin S, Nuttall F, Sawin C, Silbert C, Lee HS, Johnson-Nagel N.

Diabetes Care. 1996 Dec;19(12):1375-81.

PMID:
8941467
19.

Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

Shichiri M, Kishikawa H, Ohkubo Y, Wake N.

Diabetes Care. 2000 Apr;23 Suppl 2:B21-9.

PMID:
10860187
20.

Severe hypoglycaemia and late-life cognitive ability in older people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study.

Aung PP, Strachan MW, Frier BM, Butcher I, Deary IJ, Price JF; Edinburgh Type 2 Diabetes Study Investigators.

Diabet Med. 2012 Mar;29(3):328-36. doi: 10.1111/j.1464-5491.2011.03505.x.

PMID:
22023662

Supplemental Content

Support Center